AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 6c ; Offers Guidance

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q1 EPS of ($0.35), $0.06 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $18.3 million.

GUIDANCE:

AVITA Medical, Inc. sees FY2026 revenue of $80-85 million, versus the consensus of $126.5 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• Carnival Corp. (CCL) Tops Q3 EPS by 8c
• Iovanace Biotherapeutics (IOVA) PT Raised to $16 at TD Cowen Following Raised Outlook
• Active options: NVDA AAPL TSLA AVGO CCL NFLX BE AMD KMX META